More on MLYS

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-44.2% Growth)
- Ratings (8.3 Score)

Upcoming Events

- Earnings (11/16/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mineralys Therapeutics (NQ:MLYS)
Delayed: 20.56 +0.01 (0.05%)
Prev. Close $20.55  
Open$20.71 
52 Wk High$ 
52 Wk Low$ 
Day High$20.71 
Day Low$20.25 
P/E N/A  
EPS$ 
Volume795,984 

Friends, Peers and Foes (?): AMGN, IRON, JNJ, LLY, LXRX (more...)

Oct 22, 2026 06:40 PM Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026
Oct 20, 2026 05:35 PM Form 4 Mineralys Therapeutics, For: Oct 19 Filed by: Peterson Kristine
Oct 20, 2026 05:34 PM Form 3 Mineralys Therapeutics, For: Oct 19 Filed by: Peterson Kristine
Oct 20, 2026 05:33 PM Form 4 Mineralys Therapeutics, For: Oct 19 Filed by: COATS LONNEL
Oct 20, 2026 05:30 PM Form 3 Mineralys Therapeutics, For: Oct 19 Filed by: COATS LONNEL
Oct 19, 2026 04:37 PM Form 8-K Mineralys Therapeutics, For: Oct 16
Oct 19, 2026 04:05 PM Mineralys Therapeutics adds two directors with pharma experience
Oct 19, 2026 04:05 PM Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats
Oct 13, 2026 04:11 PM Form 144 Mineralys Therapeutics, Filed by: Rodman David Malcom
Oct 12, 2026 06:52 AM H.C. Wainwright Reiterates Buy Rating on Mineralys Therapeutics, Inc. (MLYS)
View All Articles

Entities mentioned with MLYS

View All Entities